Liraglutide as a treatment option for weight regain after laparoscopic sleeve gastrectomy in patients with obesity and higher anaesthesiologist risk
Liraglutide, at a maximum dosage of 3.0 mg, has the potential to mitigate weight regain after LSG in patients who are not appropriate candidates for revisional surgery due to various comorbidities.
Authors
- G. Tomasicchio (ORCID: https://orcid.org/0000-0001-7017-2690)
- Gennaro Martines (ORCID: https://orcid.org/0000-0001-9669-9079)
- Michele De Fazio (ORCID: https://orcid.org/0000-0002-8762-681X)
- Maria Teresa Rotelli
Institutions
- Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Frontiers in Surgery
- Published
- 2025-09-26
- DOI
- https://doi.org/10.3389/fsurg.2025.1624455
- Citations
- 1
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01